Title |
Neuromodulators for pain management in rheumatoid arthritis
|
---|---|
Published in |
Cochrane database of systematic reviews, January 2012
|
DOI | 10.1002/14651858.cd008921.pub2 |
Pubmed ID | |
Authors |
Bethan L Richards, Samuel L Whittle, Rachelle Buchbinder |
Abstract |
Pain management is a high priority for patients with rheumatoid arthritis (RA). Despite deficiencies in research data, neuromodulators have gained widespread clinical acceptance as adjuvants in the management of patients with chronic musculoskeletal pain. |
X Demographics
The data shown below were collected from the profiles of 27 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Sweden | 7 | 26% |
United States | 4 | 15% |
Brazil | 1 | 4% |
Australia | 1 | 4% |
Colombia | 1 | 4% |
United Kingdom | 1 | 4% |
Spain | 1 | 4% |
Mauritius | 1 | 4% |
Canada | 1 | 4% |
Other | 0 | 0% |
Unknown | 9 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 25 | 93% |
Scientists | 1 | 4% |
Practitioners (doctors, other healthcare professionals) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 371 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
United States | 1 | <1% |
Sri Lanka | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 367 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 55 | 15% |
Researcher | 52 | 14% |
Student > Bachelor | 50 | 13% |
Student > Ph. D. Student | 31 | 8% |
Student > Doctoral Student | 28 | 8% |
Other | 59 | 16% |
Unknown | 96 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 129 | 35% |
Nursing and Health Professions | 32 | 9% |
Psychology | 24 | 6% |
Agricultural and Biological Sciences | 11 | 3% |
Neuroscience | 11 | 3% |
Other | 52 | 14% |
Unknown | 112 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2023.
All research outputs
#1,016,716
of 22,662,201 outputs
Outputs from Cochrane database of systematic reviews
#2,281
of 12,296 outputs
Outputs of similar age
#7,040
of 245,904 outputs
Outputs of similar age from Cochrane database of systematic reviews
#28
of 234 outputs
Altmetric has tracked 22,662,201 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,296 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 245,904 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 234 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.